Rajeev A. Modi, an executive at Elanco Animal Health Inc, has reported the acquisition of 64.05 deferred stock units, according to a recent SEC filing. This acquisition, made on October 30, 2026, is part of the company’s ongoing executive compensation strategy.

The filing indicates that Modi now holds a total of 10,089.94 shares following this transaction. The deferred stock units represent the right to receive shares of Elanco's common stock or cash equivalent upon certain conditions, such as termination of employment.

Background

Elanco Animal Health Inc, identified by CIK 0001739104, operates within the pharmaceutical preparations industry. The company focuses on providing innovative solutions for animal health. Its headquarters are located at 450 Elanco Circle, Indianapolis, IN. Elanco is publicly traded under the ticker symbol ELAN.

What the Filing Says

The SEC filing, accession number 0001916473-26-000048, details Modi's acquisition of deferred stock units. The document states, "Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent." Modi's role is noted as the Executive Vice President of U.S. Pet Health and Global Digital Transformation.

Impact

This acquisition may affect Elanco's executive compensation landscape and reflects the company’s commitment to aligning executive interests with shareholder value. The pharmaceutical preparations sector is competitive, and such moves are common as companies strive to retain top talent.

What's Next

The filing does not say what happens next.